Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Ravkilde

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Clinical Chemistry|December 6, 2003
Evaluation of imprecision for cardiac troponin assays at low-range concentrationsMauro Panteghini, Franca Pagani, Kiang-Teck J Yeo, et al.
JACC. Cardiovascular Interventions|August 4, 2014
Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trialLisette Okkels Jensen, Per Thayssen, Michael Maeng, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 3, 2015
A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial)Michael Maeng, Arvydas Baranauskas, Evald Høj Christiansen, et al.
Circulation. Cardiovascular Interventions|October 4, 2012
Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary interventionLars Jakobsen, Troels Niemann, Niels Thorsgaard, et al.
American Heart Journal|August 25, 2015
Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trialLisette Okkels Jensen, Per Thayssen, Michael Maeng, et al.
Circulation. Cardiovascular Interventions|November 15, 2011
Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarctionChristian J Terkelsen, Lisette O Jensen, Hans H Tilsted, et al.
Clinical Epidemiology|September 27, 2013
Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiologyLeif Thuesen, Lisette Okkels Jensen, Hans Henrik Tilsted, et al.
Clinical Chemistry|March 19, 2005
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndromeFred S Apple, Alan H B Wu, Johannes Mair, et al.
Heart (British Cardiac Society)|January 22, 2013
Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart diseaseAziza Azimi, Mette Gitz Charlot, Christian Torp-Pedersen, et al.
Cardiology|June 5, 2010
Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart diseaseLisette Okkels Jensen, Per Thayssen, Hans Henrik Tilsted, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|December 6, 2003
Evaluation of imprecision for cardiac troponin assays at low-range concentrationsMauro Panteghini, Franca Pagani, Kiang-Teck J Yeo, et al.
JACC. Cardiovascular Interventions|August 4, 2014
Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trialLisette Okkels Jensen, Per Thayssen, Michael Maeng, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 3, 2015
A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial)Michael Maeng, Arvydas Baranauskas, Evald Høj Christiansen, et al.
Circulation. Cardiovascular Interventions|October 4, 2012
Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary interventionLars Jakobsen, Troels Niemann, Niels Thorsgaard, et al.
American Heart Journal|August 25, 2015
Randomized comparison of a sirolimus-eluting Orsiro stent with a biolimus-eluting Nobori stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome VII trialLisette Okkels Jensen, Per Thayssen, Michael Maeng, et al.
Circulation. Cardiovascular Interventions|November 15, 2011
Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarctionChristian J Terkelsen, Lisette O Jensen, Hans H Tilsted, et al.
Clinical Epidemiology|September 27, 2013
Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiologyLeif Thuesen, Lisette Okkels Jensen, Hans Henrik Tilsted, et al.
Clinical Chemistry|March 19, 2005
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndromeFred S Apple, Alan H B Wu, Johannes Mair, et al.
Heart (British Cardiac Society)|January 22, 2013
Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart diseaseAziza Azimi, Mette Gitz Charlot, Christian Torp-Pedersen, et al.
Cardiology|June 5, 2010
Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart diseaseLisette Okkels Jensen, Per Thayssen, Hans Henrik Tilsted, et al.
Pageof 9